Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Atossa Therapeutics Inc ATOS

Healthcare Biotechnology
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen... see more

Recent & Breaking News (NDAQ:ATOS)

Top Trial Firm, Cohen, Placitella & Roth, PC, Investigating Atossa Genetics, Inc, for FDA Warning Letter and Product Recall

PR Newswire October 23, 2013

Wolf Haldenstein Announces Investigation of Atossa Genetics, Inc.

Business Wire October 23, 2013

ALERT: Rosen Law Firm Announces Securities Class Action Lawsuit Against Atossa Genetics, Inc. -- ATOS

Globe Newswire October 18, 2013

Gainey McKenna & Egleston Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Atossa Genetics, Inc. -- ATOS

Globe Newswire October 18, 2013

Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Atossa Genetics, Inc.

PR Newswire October 17, 2013

Atossa Genetics, Inc. Sued by Investors After Stock Drops 46% on Drug Recall

PR Newswire October 14, 2013

Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Atossa Genetics, Inc.

Business Wire October 14, 2013

ATOSSA GENETICS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Atossa Genetics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ATOS

Globe Newswire October 14, 2013

Gregory L. Weaver Joins Atossa Genetics' Board of Directors

Marketwired October 14, 2013

Lifshitz Law Firm Announces Investigation of Atossa Genetics, Inc., Francesca's Holdings Corporation, Greenway Medical Technologies, Inc., and PVR Partners, L.P.

PR Newswire October 12, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $50,000 in Losses From Investment in Atossa Genetics, Inc. to Contact Brower Piven Before the December 9, 2013 Lead Plaintiff Deadline -- ATOS

Globe Newswire October 11, 2013

Pomerantz Law Firm Has Filed a Class Action Against Atossa Genetics, Inc. and Certain Officers -- ATOS

Globe Newswire October 10, 2013

Harwood Feffer LLP Announces Investigation of Atossa Genetics, Inc.

PR Newswire October 9, 2013

ATOSSA GENETICS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Claims on Behalf of Shareholders of Atossa Genetics, Inc.

Business Wire October 8, 2013

Finkelstein Thompson LLP Announces Investigation of Atossa Genetics, Inc.

Business Wire October 8, 2013

The Rosen Law Firm Announces Investigation of Securities Claims Against Atossa Genetics, Inc. --- ATOS

Business Wire October 8, 2013

Block & Leviton LLP Investigates Atossa Genetics, Inc. for Possible Violations of the Federal Securities Laws

PR Newswire October 8, 2013

Five Star Equities Issues New Research Reports on ATOS, CTIC, DAR and MTRN

Accesswire October 8, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atossa Genetics, Inc. - ATOS

PR Newswire October 7, 2013

ATOS SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter LLP Announces Investigation of Atossa Genetics, Inc.

Business Wire October 7, 2013